Skip to main content
Top
Published in: Journal of Cardiovascular Magnetic Resonance 1/2008

Open Access 01-12-2008 | Research

Dobutamine stress cardiovascular magnetic resonance at 3 Tesla

Authors: S Kelle, A Hamdan, B Schnackenburg, U Köhler, C Klein, E Nagel, E Fleck

Published in: Journal of Cardiovascular Magnetic Resonance | Issue 1/2008

Login to get access

Abstract

Purpose

The assessment of inducible wall motion abnormalities during high-dose dobutamine-stress cardiovascular magnetic resonance (DCMR) is well established for the identification of myocardial ischemia at 1.5 Tesla. Its feasibility at higher field strengths has not been reported. The present study was performed to prospectively determine the feasibility and diagnostic accuracy of DCMR at 3 Tesla for depicting hemodynamically significant coronary artery stenosis (≥ 50% diameter stenosis) in patients with suspected or known coronary artery disease (CAD).

Materials and methods

Thirty consecutive patients (6 women) (66 ± 9.3 years) were scheduled for DCMR between January and May 2007 for detection of coronary artery disease. Patients were examined with a Philips Achieva 3 Tesla system (Philips Healthcare, Best, The Netherlands), using a spoiled gradient echo cine sequence. Technical parameters were: spatial resolution 2 × 2 × 8 mm3, 30 heart phases, spoiled gradient echo TR/TE: 4.5/2.6 msec, flip angle 15°. Images were acquired at rest and stress in accordance with a standardized high-dose dobutamine-atropine protocol during short breath-holds in three short and three long-axis views. Dobutamine was administered using a standard protocol (10 μg increments every 3 minutes up to 40 μg dobutamine/kg body weight/minute plus atropine if required to reach target heart rate). The study protocol included administration of 0.1 mmol/kg/body weight Gd-DTPA before the cine images at rest were acquired to improve the image quality. The examination was terminated if new or worsening wall-motion abnormalities or chest pain occurred or when > 85% of age-predicted maximum heart rate was reached. Myocardial ischemia was defined as new onset of wall-motion abnormality in at least one segment. In addition, late gadolinium enhancement (LGE) was performed. Images were evaluated by two blinded readers. Diagnostic accuracy was determined with coronary angiography as the reference standard. Image quality and wall-motion at rest and maximum stress level were evaluated using a four-point scale.

Results

In 27 patients DCMR was performed successfully, no patient had to be excluded due to insufficient image quality. Twenty-two patients were examined by coronary angiography, which depicted significant stenosis in 68.2% of the patients. Patient-based sensitivity and specificity were 80.0% and 85.7% respectively and accuracy was 81.8%. Interobserver variability for assessment of wall motion abnormalities was 88% (κ = 0.760; p < 0.0001). Negative and positive predictive values were 66.7% and 92.3%, respectively. No significant differences in average image quality at rest versus stress for short or long-axis cine images were found.

Conclusion

High-dose DCMR at 3T is feasible and an accurate method to depict significant coronary artery stenosis in patients with suspected or known CAD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mandapaka S, Hundley WG: Dobutamine cardiovascular magnetic resonance: a review. J Magn Reson Imaging. 2006, 24: 499-512. 10.1002/jmri.20678.CrossRefPubMed Mandapaka S, Hundley WG: Dobutamine cardiovascular magnetic resonance: a review. J Magn Reson Imaging. 2006, 24: 499-512. 10.1002/jmri.20678.CrossRefPubMed
2.
go back to reference Nandalur KR, Dwamena BA, Choudhri AF, Nandalur MR, Carlos RC: Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. J Am Coll Cardiol. 2007, 50: 1343-1353. 10.1016/j.jacc.2007.06.030.CrossRefPubMed Nandalur KR, Dwamena BA, Choudhri AF, Nandalur MR, Carlos RC: Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. J Am Coll Cardiol. 2007, 50: 1343-1353. 10.1016/j.jacc.2007.06.030.CrossRefPubMed
3.
go back to reference Hundley WG, Hamilton CA, Thomas MS, et al: Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation. 1999, 100: 1697-1702.CrossRefPubMed Hundley WG, Hamilton CA, Thomas MS, et al: Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation. 1999, 100: 1697-1702.CrossRefPubMed
4.
go back to reference Nagel E, Lehmkuhl HB, Bocksch W, et al: Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation. 1999, 99: 763-770.CrossRefPubMed Nagel E, Lehmkuhl HB, Bocksch W, et al: Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation. 1999, 99: 763-770.CrossRefPubMed
5.
go back to reference Pennell DJ, Underwood SR, Manzara CC, et al: Magnetic resonance imaging during dobutamine stress in coronary artery disease. Am J Cardiol. 1992, 70: 34-40. 10.1016/0002-9149(92)91386-I.CrossRefPubMed Pennell DJ, Underwood SR, Manzara CC, et al: Magnetic resonance imaging during dobutamine stress in coronary artery disease. Am J Cardiol. 1992, 70: 34-40. 10.1016/0002-9149(92)91386-I.CrossRefPubMed
6.
go back to reference Plein S, Bloomer TN, Ridgway JP, Jones TR, Bainbridge GJ, Sivananthan MU: Steady-state free precession magnetic resonance imaging of the heart: comparison with segmented k-space gradient-echo imaging. J Magn Reson Imaging. 2001, 14: 230-236. 10.1002/jmri.1178.CrossRefPubMed Plein S, Bloomer TN, Ridgway JP, Jones TR, Bainbridge GJ, Sivananthan MU: Steady-state free precession magnetic resonance imaging of the heart: comparison with segmented k-space gradient-echo imaging. J Magn Reson Imaging. 2001, 14: 230-236. 10.1002/jmri.1178.CrossRefPubMed
7.
go back to reference Paetsch I, Jahnke C, Wahl A, et al: Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation. 2004, 110: 835-842. 10.1161/01.CIR.0000138927.00357.FB.CrossRefPubMed Paetsch I, Jahnke C, Wahl A, et al: Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation. 2004, 110: 835-842. 10.1161/01.CIR.0000138927.00357.FB.CrossRefPubMed
8.
go back to reference Paetsch I, Jahnke C, Ferrari VA, et al: Determination of interobserver variability for identifying inducible left ventricular wall motion abnormalities during dobutamine stress magnetic resonance imaging. Eur Heart J. 2006, 27: 1459-1464. 10.1093/eurheartj/ehi883.CrossRefPubMed Paetsch I, Jahnke C, Ferrari VA, et al: Determination of interobserver variability for identifying inducible left ventricular wall motion abnormalities during dobutamine stress magnetic resonance imaging. Eur Heart J. 2006, 27: 1459-1464. 10.1093/eurheartj/ehi883.CrossRefPubMed
9.
go back to reference Barkhausen J, Ruehm SG, Goyen M, Buck T, Laub G, Debatin JF: MR evaluation of ventricular function: true fast imaging with steady-state precession versus fast low-angle shot cine MR imaging: feasibility study. Radiology. 2001, 219: 264-269.CrossRefPubMed Barkhausen J, Ruehm SG, Goyen M, Buck T, Laub G, Debatin JF: MR evaluation of ventricular function: true fast imaging with steady-state precession versus fast low-angle shot cine MR imaging: feasibility study. Radiology. 2001, 219: 264-269.CrossRefPubMed
10.
go back to reference Hamdan A, Kelle S, Schnackenburg B, Fleck E, Nagel E: quantitative assessment of left ventricular volumes using TGrE approach after application of extracellular contrast agent at 3 Tesla. J Cardiovasc Magn Reson. 2007, 9: 845-853. 10.1080/10976640701693600.CrossRefPubMed Hamdan A, Kelle S, Schnackenburg B, Fleck E, Nagel E: quantitative assessment of left ventricular volumes using TGrE approach after application of extracellular contrast agent at 3 Tesla. J Cardiovasc Magn Reson. 2007, 9: 845-853. 10.1080/10976640701693600.CrossRefPubMed
11.
go back to reference Pennell DJ, Sechtem UP, Higgins CB, et al: Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J. 2004, 25: 1940-1965. 10.1016/j.ehj.2004.06.040.CrossRefPubMed Pennell DJ, Sechtem UP, Higgins CB, et al: Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J. 2004, 25: 1940-1965. 10.1016/j.ehj.2004.06.040.CrossRefPubMed
12.
go back to reference Nagel E, Kelle S, Fleck E: [Indications for cardiovascular magnetic resonance imaging]. Med Klin (Munich). 2005, 100: 219-225. 10.1007/s00063-005-1026-0.CrossRef Nagel E, Kelle S, Fleck E: [Indications for cardiovascular magnetic resonance imaging]. Med Klin (Munich). 2005, 100: 219-225. 10.1007/s00063-005-1026-0.CrossRef
13.
go back to reference Fischer SE, Wickline SA, Lorenz CH: Novel real-time R-wave detection algorithm based on the vectorcardiogram for accurate gated magnetic resonance acquisitions. Magn Reson Med. 1999, 42: 361-370. 10.1002/(SICI)1522-2594(199908)42:2<361::AID-MRM18>3.0.CO;2-9.CrossRefPubMed Fischer SE, Wickline SA, Lorenz CH: Novel real-time R-wave detection algorithm based on the vectorcardiogram for accurate gated magnetic resonance acquisitions. Magn Reson Med. 1999, 42: 361-370. 10.1002/(SICI)1522-2594(199908)42:2<361::AID-MRM18>3.0.CO;2-9.CrossRefPubMed
14.
go back to reference Nagel E, Lorenz C, Baer F, et al: Stress cardiovascular magnetic resonance: consensus panel report. J Cardiovasc Magn Reson. 2001, 3: 267-281. 10.1081/JCMR-100107475.CrossRefPubMed Nagel E, Lorenz C, Baer F, et al: Stress cardiovascular magnetic resonance: consensus panel report. J Cardiovasc Magn Reson. 2001, 3: 267-281. 10.1081/JCMR-100107475.CrossRefPubMed
15.
go back to reference Cerqueira MD, Weissman NJ, Dilsizian V, et al: Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002, 105: 539-542. 10.1161/hc0402.102975.CrossRefPubMed Cerqueira MD, Weissman NJ, Dilsizian V, et al: Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002, 105: 539-542. 10.1161/hc0402.102975.CrossRefPubMed
16.
go back to reference Araoz PA, Glockner JF, McGee KP, et al: 3 Tesla MR imaging provides improved contrast in first-pass myocardial perfusion imaging over a range of gadolinium doses. J Cardiovasc Magn Reson. 2005, 7: 559-564. 10.1081/JCMR-200060622.CrossRefPubMed Araoz PA, Glockner JF, McGee KP, et al: 3 Tesla MR imaging provides improved contrast in first-pass myocardial perfusion imaging over a range of gadolinium doses. J Cardiovasc Magn Reson. 2005, 7: 559-564. 10.1081/JCMR-200060622.CrossRefPubMed
17.
go back to reference Gebker R, Jahnke C, Paetsch I, et al: Diagnostic Performance of Myocardial Perfusion MR at 3 T in Patients with Coronary Artery Disease. Radiology. 2008, 247: 57-63.CrossRefPubMed Gebker R, Jahnke C, Paetsch I, et al: Diagnostic Performance of Myocardial Perfusion MR at 3 T in Patients with Coronary Artery Disease. Radiology. 2008, 247: 57-63.CrossRefPubMed
18.
go back to reference Klumpp B, Fenchel M, Hoevelborn T, et al: Assessment of myocardial viability using delayed enhancement magnetic resonance imaging at 3 Tesla. Invest Radiol. 2006, 41: 661-667. 10.1097/01.rli.0000233321.82194.09.CrossRefPubMed Klumpp B, Fenchel M, Hoevelborn T, et al: Assessment of myocardial viability using delayed enhancement magnetic resonance imaging at 3 Tesla. Invest Radiol. 2006, 41: 661-667. 10.1097/01.rli.0000233321.82194.09.CrossRefPubMed
19.
go back to reference Leiner T, de Vries M, Hoogeveen R, Vasbinder GB, Lemaire E, van Engelshoven JM: Contrast-enhanced peripheral MR angiography at 3 Tesla: initial experience with a whole-body scanner in healthy volunteers. J Magn Reson Imaging. 2003, 17: 609-614. 10.1002/jmri.10297.CrossRefPubMed Leiner T, de Vries M, Hoogeveen R, Vasbinder GB, Lemaire E, van Engelshoven JM: Contrast-enhanced peripheral MR angiography at 3 Tesla: initial experience with a whole-body scanner in healthy volunteers. J Magn Reson Imaging. 2003, 17: 609-614. 10.1002/jmri.10297.CrossRefPubMed
20.
go back to reference Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ: Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol. 2005, 40: 715-724. 10.1097/01.rli.0000184756.66360.d3.CrossRefPubMed Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ: Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol. 2005, 40: 715-724. 10.1097/01.rli.0000184756.66360.d3.CrossRefPubMed
21.
go back to reference Stuber M, Botnar RM, Fischer SE, et al: Preliminary report on in vivo coronary MRA at 3 Tesla in humans. Magn Reson Med. 2002, 48: 425-429. 10.1002/mrm.10240.CrossRefPubMed Stuber M, Botnar RM, Fischer SE, et al: Preliminary report on in vivo coronary MRA at 3 Tesla in humans. Magn Reson Med. 2002, 48: 425-429. 10.1002/mrm.10240.CrossRefPubMed
22.
go back to reference Pedersen M: Safety update on the possible causal relationship between gadolinium-containing MRI agents and nephrogenic systemic fibrosis. Journal of Magnetic Resonance Imaging. 2007, 25: 881-883. 10.1002/jmri.20983.CrossRefPubMed Pedersen M: Safety update on the possible causal relationship between gadolinium-containing MRI agents and nephrogenic systemic fibrosis. Journal of Magnetic Resonance Imaging. 2007, 25: 881-883. 10.1002/jmri.20983.CrossRefPubMed
23.
go back to reference Roes SD, Kelle S, Kaandorp TA, et al: Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction. Am J Cardiol. 2007, 100: 930-936. 10.1016/j.amjcard.2007.04.029.CrossRefPubMed Roes SD, Kelle S, Kaandorp TA, et al: Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction. Am J Cardiol. 2007, 100: 930-936. 10.1016/j.amjcard.2007.04.029.CrossRefPubMed
24.
go back to reference Kwong RY, Sattar H, Wu H, et al: Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. Circulation. 2008, 118: 1011-1020. 10.1161/CIRCULATIONAHA.107.727826.PubMedCentralCrossRefPubMed Kwong RY, Sattar H, Wu H, et al: Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. Circulation. 2008, 118: 1011-1020. 10.1161/CIRCULATIONAHA.107.727826.PubMedCentralCrossRefPubMed
25.
go back to reference Kelle S, Kokocinski T, Thouet T, Fleck E, Nagel E: 1.5 vs. 3 Tesla – reduction of contrast agent dosage for scar-imaging possible?. European Heart Journal. 2006, 27: 422-423. Kelle S, Kokocinski T, Thouet T, Fleck E, Nagel E: 1.5 vs. 3 Tesla – reduction of contrast agent dosage for scar-imaging possible?. European Heart Journal. 2006, 27: 422-423.
26.
go back to reference Stuber M, Weiss RG: Coronary magnetic resonance angiography. J Magn Reson Imaging. 2007, 26: 219-234. 10.1002/jmri.20949.CrossRefPubMed Stuber M, Weiss RG: Coronary magnetic resonance angiography. J Magn Reson Imaging. 2007, 26: 219-234. 10.1002/jmri.20949.CrossRefPubMed
27.
go back to reference Wahl A, Paetsch I, Gollesch A, et al: Safety and feasibility of high-dose dobutamine-atropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischaemia: experience in 1000 consecutive cases. Eur Heart J. 2004, 25: 1230-1236. 10.1016/j.ehj.2003.11.018.CrossRefPubMed Wahl A, Paetsch I, Gollesch A, et al: Safety and feasibility of high-dose dobutamine-atropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischaemia: experience in 1000 consecutive cases. Eur Heart J. 2004, 25: 1230-1236. 10.1016/j.ehj.2003.11.018.CrossRefPubMed
Metadata
Title
Dobutamine stress cardiovascular magnetic resonance at 3 Tesla
Authors
S Kelle
A Hamdan
B Schnackenburg
U Köhler
C Klein
E Nagel
E Fleck
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Journal of Cardiovascular Magnetic Resonance / Issue 1/2008
Electronic ISSN: 1532-429X
DOI
https://doi.org/10.1186/1532-429X-10-44

Other articles of this Issue 1/2008

Journal of Cardiovascular Magnetic Resonance 1/2008 Go to the issue